Age-stratified signals and early onset of adverse events with pregabalin: a disproportionality analysis of the FDA adverse event reporting system
Introduction Pregabalin is widely used in the management of neuropathic pain and generalized anxiety disorder. However, comprehensive real-world evidence regarding its neuropsychiatric safety profile and age-specific risk variations remains insufficient. Methods Data were retrieved from the FDA Adverse Event Reporting...